- Home
- BBIO vs ALB Comparison
BBIO vs ALB Comparison
Compare BBIO & ALB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- ALB
- Stock Information
- Founded
- BBIO 2015
- ALB 1994
- Country
- BBIO United States
- ALB United States
- Employees
- BBIO N/A
- ALB N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- ALB Major Chemicals
- Sector
- BBIO Health Care
- ALB Industrials
- Exchange
- BBIO Nasdaq
- ALB Nasdaq
- Market Cap
- BBIO 8.0B
- ALB 7.0B
- IPO Year
- BBIO 2019
- ALB 1994
- Fundamental
- Price
- BBIO $45.12
- ALB $63.75
- Analyst Decision
- BBIO Strong Buy
- ALB Hold
- Analyst Count
- BBIO 14
- ALB 20
- Target Price
- BBIO $58.85
- ALB $89.25
- AVG Volume (30 Days)
- BBIO 3.3M
- ALB 3.3M
- Earning Date
- BBIO 07-31-2025
- ALB 07-30-2025
- Dividend Yield
- BBIO N/A
- ALB 2.58%
- EPS Growth
- BBIO N/A
- ALB N/A
- EPS
- BBIO N/A
- ALB N/A
- Revenue
- BBIO $127,415,000.00
- ALB $5,093,671,000.00
- Revenue This Year
- BBIO $102.05
- ALB N/A
- Revenue Next Year
- BBIO $54.69
- ALB $10.59
- P/E Ratio
- BBIO N/A
- ALB N/A
- Revenue Growth
- BBIO N/A
- ALB N/A
- 52 Week Low
- BBIO $21.72
- ALB $49.43
- 52 Week High
- BBIO $45.48
- ALB $113.91
- Technical
- Relative Strength Index (RSI)
- BBIO 77.53
- ALB 59.33
- Support Level
- BBIO $39.65
- ALB $55.90
- Resistance Level
- BBIO $45.18
- ALB $61.23
- Average True Range (ATR)
- BBIO 1.49
- ALB 2.21
- MACD
- BBIO 0.54
- ALB 0.17
- Stochastic Oscillator
- BBIO 99.13
- ALB 79.70
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About ALB Albemarle Corporation
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.